U.S. At-Home Testing Kits Market – Industry Trends and Forecast to 2031

 미국 재택 테스트 키트 시장 분석 및 규모

미국 가정용 검사 키트 시장은 COVID-19, 성병, 만성 질환을 포함한 다양한 질환에 대한 편리하고 빠른 진단 솔루션을 제공함으로써 의료 접근성에서 중요한 역할을 합니다. 이러한 키트는 개인이 집에서 편안하게 건강을 모니터링하여 조기 발견 및 개입을 용이하게 합니다. 시장의 성장은 분산형 의료로의 전환과 사전 예방적 건강 관리에 대한 더 큰 강조를 의미하며, 궁극적으로 공중 보건 결과 개선과 의료 시스템 부담 감소에 기여합니다.

Data Bridge Market Research에서는 2023년에 21억 8천만 달러 규모였던 미국 가정용 검사 키트 시장이 2031년에는 34억 달러 규모로 성장할 것으로 예상하며, 2024년부터 2031년까지 예측 기간 동안 연평균 성장률은 5.70%가 될 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함되어 있습니다.

미국 재택 테스트 키트 시장 범위 및 세분화  

시장 정의

가정용 검사 키트는 개인이 집에서 편안하게 검사를 스스로 시행할 수 있도록 설계된 편리하고 사용하기 쉬운 진단 도구입니다. 이러한 키트에는 일반적으로 샘플 수집에 필요한 모든 구성 요소와 지침이 포함되어 있으며 측면 흐름 검사, 분자 기술 또는 면역 검사와 같은 다양한 검사 방법을 사용할 수 있습니다. 이러한 키트는 일반적으로 감염성 질환, 임신 호르몬 또는 유전적 소인과 같은 특정 건강 상태나 마커를 감지하는 데 사용됩니다.

미국 재택 테스트 키트 시장 동향

운전자

• 건강 인식 향상으로 조기 발견 가능

인구의 건강과 웰빙에 대한 인식이 높아지면서 가정용 검사 키트 시장이 크게 성장하고 있습니다. 가정용 검사 키트는 개인이 다양한 건강 매개변수를 평가할 수 있는 편리하고 접근 가능한 방법을 제공하여 예방적 건강 관리 관행을 장려합니다. 건강 의식이 높아짐에 따라 조기 감지 및 모니터링에 중점을 두면서 일반 건강 검진에서 전문 진단 검사에 이르기까지 다양한 가정용 검사 솔루션에 대한 수요가 증가하고 있습니다.

• 먼 지역이나 서비스가 부족한 지역 에서의 쉬운 접근성

재택 검사 키트의 접근성은 미국 시장 성장에 상당히 기여합니다. 기술과 유통 채널의 발전으로 이러한 키트는 광범위한 소비자에게 쉽게 제공되었습니다. 재택 검사 옵션에 쉽게 접근할 수 있어 기존 의료 환경과 관련된 장벽이 없어 편의성과 프라이버시를 제공합니다. 이러한 접근성은 의료 시설에 도달하기 어려울 수 있는 먼 지역이나 서비스가 부족한 지역에서 특히 중요합니다.

기회

• 정확한 진단 솔루션을 제공하는 기술 발전

The continuous evolution of technology, including the integration of artificial intelligence and Internet of Things (IoT) in at-home testing kits, opens doors for innovative and more accurate diagnostic solutions. These advancements not only enhance the reliability of test results but also contribute to user-friendly experiences, fostering greater consumer adoption. As the market embraces cutting-edge technologies, there is a promising opportunity for companies to differentiate themselves and capture a larger share of the U.S. at-home testing kits market.

• Personalized Healthcare Trends from the Comfort of Home

As individuals increasingly seek tailored health insights and solutions, at-home testing kits provide an opportunity for customized diagnostic and monitoring options. Companies that can develop and market specialized testing kits for genetic predispositions, nutritional needs, or specific health conditions stand to thrive in an environment where consumers are actively seeking personalized and actionable health information from the comfort of homes.

Restraints/Challenges

• Regulatory Challenges Lead to Delays in Product Approvals

Stringent regulatory requirements from agencies such as the FDA can lead to delays in product approvals and market entry. Compliance with complex regulatory frameworks poses a barrier for companies in developing, marketing, and distributing at-home testing kits, hindering the market's growth potential. These challenges increase the time and costs associated with bringing products to market and contribute to uncertainties and limitations in the industry.

• Self-Administered Tests Lacks in Accuracy  

This challenge arises from the inherent complexities of self-administered tests, potentially leading to less precise results compared to professionally conducted tests. As accuracy is paramount in diagnostic processes, the reliability of at-home testing kits becomes a concern, hindering their widespread adoption. This limitation may impact the market's growth, as users seek assurance in the accuracy of test outcomes for informed decision-making regarding their health.

This U.S. at-home testing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the U.S. at-home testing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, SalistickTM introduced a saliva-based pregnancy test kit. Boasting improved user experience and high accuracy, SalistickTM utilizes innovative technology to detect the pregnancy hormone β-hCG in saliva, offering a novel approach to early pregnancy detection

• In June 2022, CoviEasy launched a self-test rapid antigen kit for COVID-19 by Genes2Me Pvt. Ltd. in India. Accompanied by an AI-driven mobile app, the IVD product ensures ease of use and provides rapid results within 10 minutes, with an impressive accuracy rate exceeding 98%, contributing to efficient and accessible testing solutions
• In July 2021, Abbott introduced a COVID-19 home test kit in India, facilitating the detection of the SARS-CoV-2 virus in both adults and children, irrespective of symptoms. This move aimed to enhance accessibility to testing and contribute to the management of the ongoing pandemic
• In November 2020, ACON Laboratories, Inc. launched the Flowflex SARS-COV-2 Antigen Rapid Test. Designed for diagnosing individuals suspected of active COVID-19, this addition to the product portfolio marked a strategic move to broaden the company's offerings and bolster revenue streams

U.S. At-Home Testing Kits Market Scope

The U.S. at-home testing kits market is segmented on the basis of test type, type, age, sample type, usage and distribution channels. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Test type

• Pregnancy Test
• Testosterone
• STD/ STI Testing
• Chlamydia and Gonorrhoea
• HIV testing
• Diabetes
• Cholesterol Testing
• Thyroid Testing
• Infectious Diseases
• Glucose Tests
• Ovulation Predictor Test Kit
• Drug Abuse Test Kit
• Cancer Testing
• Other Test Types

Type

• Digital Monitoring Instruments
• Cups
• Sample Collection Kits
• Cassette
• Strip
• Midstream
• Test Panel
• Dip Card
• Other Form Types

Age

• Paediatric
• Adult
• Geriatric

Sample type

• Urine
• Blood
• Saliva
• Stool
• Vaginal Swab
• Semen
• Other Sample Types

Usage

• Disposable 
• Reusable

Distribution Channels

• Retail Pharmacies
• Drug Store
• Hospital Pharmacies
• Supermarket/Hypermarket
• Online Pharmacies

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The U.S. at-home testing kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for U.S. at-home testing kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the U.S. at-home testing kits market . The data is available for historic period 2016-2021.

Competitive Landscape and U.S. At-Home Testing Kits Market Share Analysis

The U.S. at-home testing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, the U.S. presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the U.S. at-home testing kits market.

Some of the major players operating in the U.S. at-home testing kits market are:

• Abbott  (U.S.)
• ACON Laboratories, Inc.  (U.S.)
• OraSure Technologies, Inc.  (U.S.)
• BD (U.S.)
• Cardinal Health  (U.S.)
• B. Braun SE (Germany)
• Siemens Healthcare GmbH  (Germany)
• QuidelOrtho Corporation (U.S.)
• Bionime Corporation  (Taiwan)
• SA Scientific Ltd. (U.S.)
• ARKRAY, Inc. (U.S.)
• Everlywell, Inc.  (U.S.)
• Sitemap (U.S.)
• Nova Biomedical  (U.S.)
• AdvaCare Pharma  (U.S.)
• Atlas Medical GmbH(U.K.)
• LifeScan IP Holdings, LLC  (U.S.)
• Chembio Diagnostics, Inc.  (U.S.)
• TaiDoc Technology Corporation  (Taiwan)
• Drägerwerk AG & Co. KGaA  (Germany)
• AccuBioTech Co., Ltd  (China)
• F. HoffmannLa Roche Ltd  (Switzerland)
• PRIMA Lab SA  (Switzerland)
• MP BIOMEDICALS  (U.S.)
• VedaLab  (France)
• Ascensia Diabetes Care Holdings AG  (Switzerland)

SKU-62908